V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210038727 | 210019108 | 1.68 | null | null | 2018-11-30 | 2018-12-22 | Alemtuzumab(INTRAVENOUS) | N | N | 210013874 | ALEMTUZUMAB |
| 210038728 | 210007729 | 1.79 | 87.7 | Curative (C) | 2015-04-08 | 2015-05-24 | Venetoclax | N | null | 210013914 | VENETOCLAX |
| 210038729 | 210007921 | 1.68 | 97.8 | Curative (C) | null | 2015-03-29 | Alemtuzumab | Y | N | 210014311 | ALEMTUZUMAB |
| 210038730 | 210007983 | 1.59 | null | Disease modification (D) | 2016-02-19 | 2016-09-25 | CARBOPLATIN | 2 | N | 210014466 | CARBOPLATIN |
| 210038732 | 210019251 | 1.6 | 62 | Palliative (P) | 2015-09-22 | 2015-09-27 | CHOP - 14 days | 2 | N | 210014747 | PENTOSTATIN |
| 210038733 | 210008157 | 1.71 | 79.1 | Curative (C) | 2018-08-27 | 2019-01-09 | Cyclophosphamide + Vincristine | Y | N | 210014775 | CARBOPLATIN + ETOPOSIDE |
| 210038735 | 210008566 | 1.69 | null | Curative (C) | 2016-03-29 | 2018-08-20 | DARATUMUMAB | N | N | 210015709 | PEMBROLIZUMAB |
| 210038736 | 210010805 | null | 70.8 | Curative (C) | 2017-07-12 | 2017-07-15 | Alemtuzumab + Cyclophos TBI Allo | 02 | null | 210027036 | CARBOPLATIN + ETOPOSIDE + VINCRISTINE |
| 210038737 | 210010878 | 1.68 | 54.7 | Curative (C) | 2018-04-03 | 2018-04-05 | BR14 TRIAL | N | N | 210027529 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 210038738 | 210012159 | 1.73 | null | Curative (C) | 2017-04-20 | 2017-04-20 | PNET 4 HIT-SIOP Maintenance | Y | N | 210033375 | CYCLO + FLUDARABINE + RITUXIMAB |
| 210038739 | 210012321 | null | null | Curative (C) | 2019-05-29 | 2019-05-29 | ICE (no GCSF) | N | null | 210034115 | NHL 2003 |
| 210038740 | 210013419 | null | 76.4 | Palliative (P) | 2019-06-03 | 2019-06-04 | CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE | N | N | 210040628 | CAPECITABINE |
| 210038741 | 210013791 | 1.74 | 13.3 | Curative (C) | 2019-10-06 | 2019-10-09 | ABVD | N | N | 210028705 | BEAM |
| 210038743 | 210038852 | 1.75 | 62 | Adjuvant (A) | 2019-03-25 | 2019-06-04 | TEMOZOLOMIDE | 02 | Y | 210002777 | TEMOZOLOMIDE |
| 210038744 | 210017530 | 1.69 | 72.9 | Curative (C) | 2018-06-02 | 2019-08-02 | Temozolomide 150mg/m2 | N | N | 210004002 | TEMOZOLOMIDE |
| 210038745 | 210025022 | 1.92 | 32.4 | Curative (C) | 2015-09-25 | 2015-10-06 | ALL UKALL2011 Del Int C Reind PAsp | Y | N | 210005198 | UKALL2011 |
| 210038746 | 210038334 | 1.43 | 26.8 | Curative (C) | 2019-07-22 | 2019-07-22 | ALL UKALL2011 Cap Int Maint C PAsp | Y | null | 210005410 | UKALL2011 |
| 210038749 | 210032672 | 0 | 27.6 | Curative (C) | 2018-05-27 | 2019-05-31 | ALL UKALL2011 Maintenance A1 | Y | N | 210005614 | UKALL2011 |
| 210038750 | 210005428 | 0 | 18 | Curative (C) | 2013-12-19 | 2016-03-04 | ALL UKALL2011 Maintenance C2 | Y | N | 210006133 | UKALL2011 |
| 210038751 | 210005476 | 1.07 | 28.1 | Curative (C) | 2015-12-02 | 2018-05-04 | ALL UKALL2011 Maintenance A3 | Y | N | 210006371 | UKALL2011 |
| 210038752 | 210005539 | 0 | 22.8 | Curative (C) | 2016-07-28 | 2016-10-21 | ALL UKALL2011 Maintenance A1 | N | N | 210006602 | UKALL2011 |
| 210038754 | 210005640 | 0 | 29.7 | Palliative (P) | 2017-05-29 | 2017-06-17 | ALL UKALL2011 Ind A Std Dex (PAsp) | N | N | 210007091 | UKALL2011 |
| 210038756 | 210017897 | null | 23.5 | Curative (C) | 2018-06-13 | 2018-10-04 | ALL UKALL2011 Del Int C Reind PAsp | N | N | 210007468 | UKALL2011 |
| 210038757 | 210005760 | 1.05 | null | Curative (C) | 2015-01-10 | 2015-07-23 | ALL UKALL2011 Maintenance B2 | Y | N | 210007627 | UKALL2011 |
| 210038758 | 210005805 | null | 120 | Curative (C) | 2014-08-14 | 2015-06-25 | ALL UKALL2011 Maintenance B1 | Y | N | 210007768 | UKALL 2011 |
| 210038759 | 210005850 | 1.83 | 64.3 | Curative (C) | 2015-08-09 | 2015-12-23 | ALL UKALL2011 TRIAL | 02 | N | 210007896 | UKALL 2011 |
| 210038760 | 210005888 | null | 16.1 | Curative (C) | null | 2014-10-13 | ALL UKALL2011 Consolidation A | Y | null | 210008060 | UKALL 2011 |
| 210038761 | 210005899 | 0 | 36.9 | Curative (C) | 2013-04-03 | 2015-06-19 | ALL UKALL2011 Std Int Maint B | Y | N | 210008074 | UKALL 2011 |
| 210038763 | 210029999 | null | 17 | Curative (C) | 2017-02-10 | 2017-09-14 | ALL UKALL2011 TRIAL | Y | null | 210008355 | UKALL 2011 |
| 210038764 | 210006006 | 0 | 28.1 | Curative (C) | 2017-02-22 | 2017-08-09 | Methotrexate intrathecal | N | N | 210008484 | METHOTREXATE INTRATHECAL |
| 210038766 | 210018129 | 1.8 | 11.9 | Curative (C) | 2017-02-14 | 2017-02-14 | Methotrexate Intrathecal (any age) | Y | N | 210008601 | METHOTREXATE INTRATHECAL |
| 210038767 | 210018154 | 0 | 19.1 | Curative (C) | 2014-12-28 | 2014-12-28 | Methotrexate intrathecal | Y | N | 210008769 | METHOTREXATE INTRATHECAL |
| 210038768 | 210018164 | 1.83 | 17.1 | Curative (C) | 2016-05-05 | 2016-07-07 | Methotrexate intrathecal | N | N | 210008823 | METHOTREXATE INTRATHECAL |
| 210038769 | 210006115 | 1.81 | 19.6 | Curative (C) | 2019-10-21 | 2020-01-11 | Methotrexate intrathecal | N | N | 210008880 | METHOTREXATE INTRATHECAL |
| 210038770 | 210006222 | 0 | 77.6 | Curative (C) | 2016-07-22 | 2017-02-05 | Methotrexate Intrathecal (any age) | Y | null | 210009402 | METHOTREXATE INTRATHECAL |
| 210038771 | 210006241 | 1.8 | 74.4 | Curative (C) | 2017-03-26 | 2017-12-18 | Methotrexate intrathecal | N | N | 210009453 | METHOTREXATE INTRATHECAL |
| 210038772 | 210006284 | null | 80.7 | Curative (C) | 2014-10-23 | 2015-03-25 | UKALL14- Maintenance | Y | N | 210009681 | UKALL2014 |
| 210038773 | 210006298 | 1.67 | 73 | Curative (C) | 2016-09-14 | 2017-04-02 | UKALL14- Ph 2 Induction | Y | null | 210009764 | UKALL2014 |
| 210038774 | 210006307 | 1.74 | null | Curative (C) | null | 2014-07-21 | UKALL14- Intens/CNS Proph | N | null | 210009769 | UKALL2014 |
| 210038775 | 210006339 | 1.64 | null | Curative (C) | 2017-02-07 | 2017-06-28 | UKALL 14 TRIAL | Y | null | 210009828 | UKALL2014 |
| 210038776 | 210006347 | 1.69 | 74.6 | Curative (C) | 2016-11-18 | 2016-12-16 | UKALL14- Ph 1 Induction | Y | N | 210009833 | UKALL2014 |
| 210038777 | 210006373 | 1.77 | 84 | Neo-adjuvant (N) | 2016-06-11 | 2016-06-13 | UKALL14- Maintenance | null | N | 210009866 | UKALL2014 |
| 210038778 | 210006422 | 1.85 | 85.4 | Curative (C) | 2016-11-29 | 2016-11-29 | UKALL14- Intens/CNS Proph | Y | N | 210010026 | UKALL2014 |
| 210038779 | 210025664 | 0 | 21.6 | Curative (C) | 2017-02-10 | 2017-02-15 | null | N | Y | 210010067 | NOT MATCHED |
| 210038780 | 210006446 | 1.06 | 29 | Curative (C) | 2017-06-29 | 2017-06-29 | CNS Infant HGG | Y | null | 210010115 | NOT MATCHED |
| 210038781 | 210025682 | null | 63.4 | Curative (C) | 2015-02-03 | 2016-05-05 | CNS ATRT ICE Ifos/Carboplatin/Etoposide + GCSF | 0 | N | 210010142 | NOT MATCHED |
| 210038782 | 210006471 | 1.83 | 18 | Curative (C) | 2015-08-08 | 2015-11-13 | TEMOZOLOMIDE + THALIDOMIDE | 1 | N | 210010163 | NOT MATCHED |
| 210038783 | 210025695 | 0 | 29.1 | Curative (C) | 2019-08-12 | 2020-03-10 | CNS Ependy II Vinc/HD MTX + valproate | N | N | 210010213 | NOT MATCHED |
| 210038785 | 210006520 | null | null | Curative (C) | 2016-09-08 | 2016-09-27 | Trial Unspecified | N | N | 210010330 | TRIAL |
| 210038786 | 210006535 | 1.57 | 140 | Curative (C) | 2017-11-09 | 2017-11-09 | IBRUTINIB | N | N | 210010379 | IBRUTINIB |